Trial Outcomes & Findings for , "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?" (NCT NCT02517294)

NCT ID: NCT02517294

Last Updated: 2024-02-13

Results Overview

Mucosal damage as quantified by presence and severity of bleeding immediately after passage of the NTT through the nasopharynx.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

73 participants

Primary outcome timeframe

within approximately 4hrs of surgery (day of surgery)

Results posted on

2024-02-13

Participant Flow

Participant milestones

Participant milestones
Measure
Standard Nasotracheal Tube
Nasotracheal intubation using 'standard' side-beveled nasotracheal tubes Standard nasotracheal tube: standard nasotracheal tube for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Parker Flex-tip Nasotracheal Tube
Nasotracheal intubation using 'experimental' flex-tip midline-beveled nasotracheal tubes Parker flex-tip nasotracheal tube: specially designed nasotracheal tube used for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Overall Study
STARTED
38
35
Overall Study
COMPLETED
38
35
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard Nasotracheal Tube
n=38 Participants
Nasotracheal intubation using 'standard' side-beveled nasotracheal tubes Standard nasotracheal tube: standard nasotracheal tube for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Parker Flex-tip Nasotracheal Tube
n=35 Participants
Nasotracheal intubation using 'experimental' flex-tip midline-beveled nasotracheal tubes Parker flex-tip nasotracheal tube: specially designed nasotracheal tube used for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Total
n=73 Participants
Total of all reporting groups
Age, Categorical
<=18 years
38 Participants
n=38 Participants
35 Participants
n=35 Participants
73 Participants
n=73 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=38 Participants
0 Participants
n=35 Participants
0 Participants
n=73 Participants
Age, Categorical
>=65 years
0 Participants
n=38 Participants
0 Participants
n=35 Participants
0 Participants
n=73 Participants
Age, Continuous
6.13 years
STANDARD_DEVIATION 1.98 • n=38 Participants
6.43 years
STANDARD_DEVIATION 2.20 • n=35 Participants
6.27 years
STANDARD_DEVIATION 2.08 • n=73 Participants
Sex: Female, Male
Female
12 Participants
n=38 Participants
11 Participants
n=35 Participants
23 Participants
n=73 Participants
Sex: Female, Male
Male
26 Participants
n=38 Participants
24 Participants
n=35 Participants
50 Participants
n=73 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
38 participants
n=38 Participants
35 participants
n=35 Participants
73 participants
n=73 Participants
BMI
16.9 kg/m^2
STANDARD_DEVIATION 3.33 • n=38 Participants
16.9 kg/m^2
STANDARD_DEVIATION 4.46 • n=35 Participants
16.9 kg/m^2
STANDARD_DEVIATION 3.88 • n=73 Participants

PRIMARY outcome

Timeframe: within approximately 4hrs of surgery (day of surgery)

Mucosal damage as quantified by presence and severity of bleeding immediately after passage of the NTT through the nasopharynx.

Outcome measures

Outcome measures
Measure
Standard Nasotracheal Tube
n=38 Participants
Nasotracheal intubation using 'standard' side-beveled nasotracheal tubes Standard nasotracheal tube: standard nasotracheal tube for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Parker Flex-tip Nasotracheal Tube
n=35 Participants
Nasotracheal intubation using 'experimental' flex-tip midline-beveled nasotracheal tubes Parker flex-tip nasotracheal tube: specially designed nasotracheal tube used for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Number of Participants With Epistaxis
11 Participants
2 Participants

SECONDARY outcome

Timeframe: perioperative, immediate during intervention - expected 2hrs (day of surgery)

Presence and degree of severe impingement of the nasotracheal tube during nasotracheal intubation

Outcome measures

Outcome measures
Measure
Standard Nasotracheal Tube
n=38 Participants
Nasotracheal intubation using 'standard' side-beveled nasotracheal tubes Standard nasotracheal tube: standard nasotracheal tube for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Parker Flex-tip Nasotracheal Tube
n=35 Participants
Nasotracheal intubation using 'experimental' flex-tip midline-beveled nasotracheal tubes Parker flex-tip nasotracheal tube: specially designed nasotracheal tube used for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Number of Participants With Nasotracheal Tube Impingement
6 Participants
3 Participants

SECONDARY outcome

Timeframe: Participants will be followed for the duration of the hospital stay, an expected average of 6 hours

ongoing nasal bleeding in the recovery unit

Outcome measures

Outcome measures
Measure
Standard Nasotracheal Tube
n=38 Participants
Nasotracheal intubation using 'standard' side-beveled nasotracheal tubes Standard nasotracheal tube: standard nasotracheal tube for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Parker Flex-tip Nasotracheal Tube
n=35 Participants
Nasotracheal intubation using 'experimental' flex-tip midline-beveled nasotracheal tubes Parker flex-tip nasotracheal tube: specially designed nasotracheal tube used for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Number of Participants With Postoperative Epistaxis
1 Participants
0 Participants

SECONDARY outcome

Timeframe: end of surgery until time of discharge, approximately 4hrs

evidence of glottic edema/injury in the immediate postoperative time frame

Outcome measures

Outcome measures
Measure
Standard Nasotracheal Tube
n=38 Participants
Nasotracheal intubation using 'standard' side-beveled nasotracheal tubes Standard nasotracheal tube: standard nasotracheal tube for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Parker Flex-tip Nasotracheal Tube
n=35 Participants
Nasotracheal intubation using 'experimental' flex-tip midline-beveled nasotracheal tubes Parker flex-tip nasotracheal tube: specially designed nasotracheal tube used for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Number of Participants With Postoperative Croup
0 Participants
1 Participants

SECONDARY outcome

Timeframe: emergence from anesthesia to meeting discharge criteria, approximately 4hrs

Outcome measures

Outcome measures
Measure
Standard Nasotracheal Tube
n=38 Participants
Nasotracheal intubation using 'standard' side-beveled nasotracheal tubes Standard nasotracheal tube: standard nasotracheal tube for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Parker Flex-tip Nasotracheal Tube
n=35 Participants
Nasotracheal intubation using 'experimental' flex-tip midline-beveled nasotracheal tubes Parker flex-tip nasotracheal tube: specially designed nasotracheal tube used for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Time to Discharge in Minutes
32.1 minutes
Standard Deviation 13.5
30.4 minutes
Standard Deviation 10.8

Adverse Events

Standard Nasotracheal Tube

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Parker Flex-tip Nasotracheal Tube

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Katrin Post-Martens

Nemours

Phone: 904-330-9942

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place